Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
NCT: NCT05968898 · RECRUITING
Brief Summary
This is a pragmatic clinical trial that will study the effect of a radiomics-based computer-aided diagnosis (CAD) tool on clinicians' management of pulmonary nodules (PNs) compared to usual care. Adults aged 35-89 years with 8-30mm PNs evaluated at Penn Medicine PN clinics will undergo 1:1 randomization to one of two groups, defined by the PN malignancy risk stratification strategy used by evaluating clinicians: 1) usual care or 2) usual care + use of a radiomics-based CAD tool.
Frequently Asked Questions
What is Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES?
Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES is a clinical trial registered under NCT05968898. Current status: RECRUITING.
What is the status of NCT05968898?
The current status of NCT05968898 (Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES) is: RECRUITING.
When did Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES start?
Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES started on 2024-01-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.